新京报贝壳财经讯 11月1日，中科寒武纪科技股份有限公司（即"寒武纪"，688256.SH）发布《关于使 用部分闲置募集资金暂时补充流动资金的公告》。 公示显示，公司于2025年10月31日召开第二届董事会第三十八次会议、第二届监事会第二十七次会议， 审议通过了《关于增加募集资金投资项目实施主体及实施地点的议案》《关于使用募集资金对全资子公 司增资以实施募投项目的议案》，同意新增全资子公司上海寒武纪作为公司募集资金投资项目——"面 向大模型的芯片平台项目""面向大模型的软件平台项目"的实施主体，与公司共同实施上述募投项目。 编辑 黄鑫宇 校对 卢茜 根据公司募集资金投资项目的使用计划及建设进度，公司在确保不影响募集资金投资项目建设进度的前 提下，为了提高募集资金使用效率、满足公司经营对流动资金的需求，公司及上海寒武纪使用不超过人 民币10亿元（含本数）闲置募集资金暂时补充流动资金，使用期限为自董事会审议通过之日起12个月， 并将通过募集资金专户实施，并且公司及上海寒武纪将根据募投项目的进展及需求情况将上述募集资金 及时归还至募集资金专用账户。 寒武纪表示，本次使用部分闲置募集资金暂时补充流动资金仅限于公司及上 ...

人民财讯10月31日电，寒武纪(688256)10月31日公告，拟新增全资子公司上海寒武纪、深圳分公司、安 徽寒武纪、西安寒武纪作为公司募集资金投资项目"面向大模型的芯片平台项目"、"面向大模型的软件 平台项目"的实施主体，公司将与上述公司共同实施上述募投项目。公司同意使用募集资金10亿元对上 海寒武纪进行增资；使用募集资金8000万元对安徽寒武纪进行增资；使用募集资金8000万元对西安寒武 纪进行增资；同意在上海寒武纪及其深圳分公司、安徽寒武纪、西安寒武纪分别设立募集资金专户，并 授权公司管理层签署办理开立募集资金专户的监管协议。 ...

(本文来自第一财经) 寒武纪公告，公司新增全资子公司上海寒武纪、深圳分公司、安徽寒武纪、西安寒武纪作为"面向大模 型的芯片平台项目"、"面向大模型的软件平台项目"的实施主体，公司将与上述公司共同实施上述募投 项目。公司将使用募集资金100,000万元人民币对上海寒武纪进行增资，8,000万元人民币对安徽寒武纪 进行增资，8,000万元人民币对西安寒武纪进行增资。该调整未改变募投项目的投资总额、募集资金投 入额、建设内容等，不会对公司的正常经营产生重大不利影响。 ...

Core Insights - The introduction of the "light asset, high R&D investment" recognition standard has led to a significant increase in the number of companies applying for refinancing on the Sci-Tech Innovation Board, with 9 companies submitting applications totaling 24.796 billion yuan [1][2] - This policy effectively addresses the financing bottleneck for "light asset, high R&D investment" enterprises, promoting resource allocation towards technological innovation [1][2] - The policy is expected to further establish the Sci-Tech Innovation Board as a core platform for nurturing new productive forces and supporting technological self-reliance [1] Group 1: Company Actions - Cambrian Technology announced a plan to raise 4.98 billion yuan through a specific issuance of A-shares, with over 30% of the funds allocated for non-capital expenditures related to R&D [1][2] - The company indicated that 87.25% of the raised funds would be used for personnel salaries and product trial costs, emphasizing its commitment to R&D [2] - Dize Pharmaceutical became the first company to complete refinancing under the new standard, adjusting its financing scale to focus on core projects, thereby accelerating its clinical and industrialization processes [3] Group 2: Industry Impact - The "light asset, high R&D investment" standard enhances the financing convenience for tech-driven companies, allowing them to increase R&D investments and improve their R&D capabilities [2][4] - The policy has improved the transparency and efficiency of refinancing reviews, providing greater flexibility for companies in need of funding [4] - It is estimated that over a hundred companies on the Sci-Tech Innovation Board may meet the "light asset, high R&D investment" criteria, although only a few have submitted refinancing applications so far [4] Group 3: Recommendations - Industry experts suggest that regulatory bodies should continue to strengthen policy promotion and provide operational guidance to help companies and intermediaries better understand and apply the new standards [5]